BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21570824)

  • 1. Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.
    Laugsand EA; Fladvad T; Skorpen F; Maltoni M; Kaasa S; Fayers P; Klepstad P
    Eur J Cancer; 2011 Jul; 47(11):1682-91. PubMed ID: 21570824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.
    Laugsand EA; Skorpen F; Kaasa S; Sabatowski R; Strasser F; Fayers P; Klepstad P
    Clin Transl Gastroenterol; 2015 Jun; 6(6):e90. PubMed ID: 26087058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
    Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
    Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
    Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
    Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do variations in the 5-HT3A and 5-HT3B serotonin receptor genes (HTR3A and HTR3B) influence the occurrence of postoperative vomiting?
    Rueffert H; Thieme V; Wallenborn J; Lemnitz N; Bergmann A; Rudlof K; Wehner M; Olthoff D; Kaisers UX
    Anesth Analg; 2009 Nov; 109(5):1442-7. PubMed ID: 19713259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two naturally occurring variants of the serotonin receptor gene HTR3C are associated with nausea in pregnancy.
    Goecke TW; Ekici AB; Niesler B; Loehberg CR; Hammer C; Rappold G; Schanze D; Straub V; Altmann HH; Strissel P; Strick R; Beckmann MW; Fasching PA
    Acta Obstet Gynecol Scand; 2010; 89(1):7-14. PubMed ID: 20021265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia.
    Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY
    Minerva Anestesiol; 2011 Jan; 77(1):33-9. PubMed ID: 21150856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of opioid induced nausea and vomiting in sickle cell disease.
    Shord SS; Chew L; Villano J
    Am J Hematol; 2008 Mar; 83(3):196-9. PubMed ID: 17724690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients.
    Colombo F; Pintarelli G; Galvan A; Noci S; Corli O; Skorpen F; Klepstad P; Kaasa S; Pigni A; Brunelli C; Roberto A; Piazza R; Pirola A; Gambacorti-Passerini C; Caraceni AT
    Sci Rep; 2020 Jan; 10(1):542. PubMed ID: 31953506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Loci modulate opioid therapy response for cancer pain.
    Galvan A; Skorpen F; Klepstad P; Knudsen AK; Fladvad T; Falvella FS; Pigni A; Brunelli C; Caraceni A; Kaasa S; Dragani TA
    Clin Cancer Res; 2011 Jul; 17(13):4581-7. PubMed ID: 21622719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental and genetic factors associated with morphine response in the postoperative period.
    Coulbault L; Beaussier M; Verstuyft C; Weickmans H; Dubert L; Trégouet D; Descot C; Parc Y; Lienhart A; Jaillon P; Becquemont L
    Clin Pharmacol Ther; 2006 Apr; 79(4):316-24. PubMed ID: 16580900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of nausea and vomiting after high-dose cyclophosphamide.
    Fetting JH; Grochow LB; Folstein MF; Ettinger DS; Colvin M
    Cancer Treat Rep; 1982 Jul; 66(7):1487-93. PubMed ID: 7093965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting.
    Janicki PK; Sugino S
    Exp Brain Res; 2014 Aug; 232(8):2613-25. PubMed ID: 24792505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of prophylactic antiemetic treatment in cancer patients receiving radiotherapy.
    Mystakidou K; Kouloulias V; Nikolaou V; Tsilika E; Lymperopoulou G; Balafouta M; Kouvaris I; Kelekis A; Gouliamos A
    J BUON; 2010; 15(1):29-35. PubMed ID: 20414924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nausea and vomiting in terminal cancer patients.
    Reuben DB; Mor V
    Arch Intern Med; 1986 Oct; 146(10):2021-3. PubMed ID: 3767547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of opioids during short-term administration: effect of age, gender, and race.
    Cepeda MS; Farrar JT; Baumgarten M; Boston R; Carr DB; Strom BL
    Clin Pharmacol Ther; 2003 Aug; 74(2):102-12. PubMed ID: 12891220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.